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Abstract: Tuberculosis (TB), the leading single infectious diseases killer globally, is driven by poverty.
Conversely, having TB worsens impoverishment. During TB illness, lost income and out-of-pocket
costs can become “catastrophic”, leading patients to abandon treatment, develop drug-resistance,
and die. WHO’s 2015 End TB Strategy recommends eliminating catastrophic costs and providing
socioeconomic support for TB-affected people. However, there is negligible evidence to guide the
design and implementation of such socioeconomic support, especially in low-income, TB-endemic
countries. A national, multi-sectoral workshop was held in Kathmandu, Nepal, on the 11th and
12th September 2019, to develop a shortlist of feasible, locally appropriate socioeconomic support
interventions for TB-affected households in Nepal, a low-income country with significant TB burden.
The workshop brought together key stakeholders in Nepal including from the Ministry of Health and
Population, Department of Health Services, Provincial Health Directorate, Health Offices, National
TB Program (NTP); and TB/Leprosy Officers, healthcare workers, community health volunteers,
TB-affected people, and external development partners (EDP). During the workshop, participants
reviewed current Nepal NTP data and strategy, discussed the preliminary results of a mixed-methods
study of the socioeconomic determinants and consequences of TB in Nepal, described existing and
potential socioeconomic interventions for TB-affected households in Nepal, and selected the most
promising interventions for future randomized controlled trial evaluations in Nepal. This report
describes the activities, outcomes, and recommendations from the workshop.
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1. Introduction
Tuberculosis (TB), the archetypal disease of poverty, kills 1.5 million people each year [1] and
typifies health inequity [2–6]. Not only do poorer people have higher likelihood of TB exposure,
infection and disease, but they are also more likely to have difficulties in accessing TB diagnosis and
care, and to become poorer due to their illness (the “medical poverty trap”) [6–8]. Among the reasons
behind this are stigma (both TB- and poverty-related), hidden costs of “free” TB diagnosis and care,
and a lack of access to social protection (e.g., health and sickness insurance) [9,10], all of which hamper
the ability of TB-affected households to access and engage with TB services [11,12]. This can lead to
catastrophic TB-related costs and compound impoverishment, especially in the poorest TB-affected
households of TB endemic low- and middle-income countries (LMICs) [13–16].
The Sustainable Development Goals (SDGs) recognise that health, poverty, and wellbeing are
inextricably linked and must all be addressed in concert [17]. Aligned with the SDGs, the World Health
Organization’s (WHO) 2015 End TB Strategy [18] includes a target of “zero TB-affected families facing
catastrophic costs” by 2020. However, national TB patient costs surveys have been performed in fewer
than 20 countries to date and the costs estimated from these surveys suggest that we are not on course to
meet WHO’s catastrophic costs target [19]. To eliminate TB-affected household costs, the End TB Strategy
advocates provision of social and economic (socioeconomic) support for TB-affected households [18].
Socioeconomic support could be achieved through long-term national social protection schemes (social
security protection and guarantees aimed at preventing or alleviating poverty, vulnerability, and social
exclusion) [20] and/or other socioeconomic interventions for TB-affected households including but not
limited to cash transfers, mutual support groups, or nutritional support, targeted especially towards
the poorest and most vulnerable [21,22]. There is limited evidence to guide the implementation of the
End TB Strategy policy change regarding socioeconomic support and it remains unclear how such
support can be delivered to TB-affected households in practical, achievable ways, especially in LMICs.
To address this knowledge gap in Nepal, a low-income TB-endemic country, a mixed-methods
study was conducted, which integrated: (i) a cohort study of people with and without TB to evaluate
the socioeconomic impact of TB in Nepal; (ii) a qualitative study gathering opinions of key stakeholders
on the barriers and facilitators to accessing and engaging with TB diagnosis and care in Nepal; and (iii)
a national, multi-sectoral workshop with the same key stakeholders to review the preliminary results of
the cohort and qualitative studies and to create a shortlist of feasible, locally-appropriate socioeconomic
interventions for TB-affected households. The final results of the cohort and qualitative study will
be reported elsewhere. Here, we report the activities, outcomes, and recommendations from the
national workshop.
2. Workshop Overview
A national workshop, the first in Nepal to specifically address socioeconomic support for
TB-affected households, was conducted over two days on the 11th and 12th September 2019 in
Kathmandu, Nepal. Sixty-five national-, provincial-, and community-level stakeholder participants
from multiple sectors participated in the workshop including: the Ministry of Health and
Population (MoHP), Department of Health Services, National Tuberculosis Control Center (NTCC),
Provincial Health Directorate, Health Offices, and partner organizations working in TB (including
non-governmental and civil-society organizations); and also TB/Leprosy Officers, community leaders,
female community health volunteers (FCHVs), and people with TB.
Prior to the workshop, we conducted a review of the existing global evidence on socioeconomic
support for TB-affected people and the ongoing studies addressing the socioeconomic impact and
consequences of TB in Nepal. This review fed into the workshop itself, which was divided into
two complementary sections (see Supplementary Files for agenda and group work materials).
Alongside presentations from the MoHP and NTC, Section 1 of the workshop consisted of presentations
summarizing our review and preliminary findings of ongoing studies in Nepal, which were then
discussed and debated among participants. Section 2 of the workshop focused on multi-disciplinary
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small group work to: (i) identify the existing psychosocial and economic support available for
TB-affected households in Nepal, suggest refinements to these packages, and/or identify elements that
could contribute to new support packages; (ii) consider targeting of the intervention (e.g., who should
receive support) and potential funding sources; and (iii) design and vote anonymously to select the
most feasible, acceptable, and locally appropriate designs for interventions to evaluate during a future
randomized controlled trial.
2.1. A Review of the Existing Evidence on Socioconomic Support for TB-Affected People
In many resource-constrained settings, including the Indian sub-continent and Nepal,
out-of-pocket payments constitute the majority of total health expenditure [23]. These payments put
an enormous economic strain on patients and their households, leading to a substantial proportion
incurring catastrophic health expenditure. Where available, social protection can defray such
out-of-pocket expenses and mitigate catastrophic health expenditure, especially for poverty-related
diseases such as TB, which are also associated with profound loss of income [9,10,24]. However,
despite social protection coverage continuing to expand, only one quarter of people worldwide have
adequate social protection cover and more than half of people have no social protection coverage
whatsoever [24]. This dearth of social protection is especially concentrated in low-income countries,
in which less than 20% of people are covered [25].
It has long been recognised that social protection has the potential to contribute to TB control
and elimination [7]. With regards to TB-specific interventions (e.g., those focused only towards
people affected by TB), randomised controlled trials, systematic reviews and meta-analyses have
shown that TB treatment outcomes can be improved by cash transfers [26] and psycho-emotional
and/or socioeconomic support packages [27–29]. Other studies have shown that regional or national
social protection programmes can be “TB-sensitive” or “TB-inclusive” (e.g., support TB-affected
people although not being primarily directed towards them) and contribute to improving TB treatment
outcomes [30–32] and reducing TB incidence, prevalence, and mortality [9,10]. Indeed, social protection
and socioeconomic support is not only included as part of a key pillar of the End TB Strategy, but also
in the WHO’s clinical TB treatment guidelines [33].
Nepal is a lower-income country with a TB case notification rate of 151 per 100,000 people [34].
In Nepal, 30% of TB cases are missed (e.g., not diagnosed, notified, or treated) and TB is associated
with significant mortality, being the seventh leading cause of death [34]. WHO and World Bank data
suggest that less than half the population is reached by a basic social protection floor and one-quarter
lives below the poverty line [35]. Despite established directly observed therapy (DOT), expansion of
GeneXpert molecular diagnostic capabilities, and increased active case finding activities, delivery of
TB care in Nepal is hampered by profound geographical challenges, including mountainous areas
with poor road access, which can negatively impact TB treatment and prevention outcomes [34–38].
In addition, cohort studies in Nepal have found that TB stigma and discrimination in communities,
hospitals, households, and especially self-stigmatization by people with TB, is prevalent [39–41].
2.2. Ongoing Studies Addressing the Socioeconomic Impact of TB in Nepal
Although no nationally representative TB patient costs survey has yet been completed in
Nepal—a national survey is planned for 2021 with support from WHO—there have been two major
longitudinal cohort studies using adapted WHO TB Patient Costs Survey methods administered at
multiple time points during TB treatment. Both studies were implemented by Birat Nepal Medical
Trust (BNMT), the first conducted during a TB-REACH Wave 5 Project and the second during the EU
Horizon2020-funded IMPACT-TB Active Case Finding Project (www.impacttbproject.org). The findings
of both studies were presented by BNMT team members at the workshop [42].
The surveys measured the economic impact of TB on affected households through measurements
of: direct costs (out-of-pocket medical expenses, such as medicines and clinics; and non-medical
expenses, including travel and accommodation related to clinics and additional food expenditure);
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and indirect costs (including lost time and income, opportunity costs, and coping strategies) [43].
The results showed that the economic burden on TB-affected households was high, especially due to
costs relating to travel, lost income, and associated with seeking a mixture of both public and private
healthcare. The prevalence of catastrophic costs of TB-affected households (total TB associated costs of
more than 20% of the same TB-affected household’s annual income) [13,43,44] was high in both studies
(53% and 49%, respectively) [42].
Other key findings of the studies were high prevalence of food insecurity amongst TB-affected
households, and access to and engagement with TB diagnosis and care being associated with worsening
poverty [42]. Active case finding (ACF) was able to mitigate some of these costs, especially those
incurred pre-treatment, but was not able to fully eliminate catastrophic costs or reduce poverty or
food insecurity. These results indicate that ACF alone will be insufficient to achieve elimination of
catastrophic costs in line with the WHO 2015 End TB Strategy and suggest that there may be synergistic
benefit from ACF being combined with integrated and comprehensive socioeconomic support and
social protection packages [3,42].
In addition to the economic impact of TB, the psychosocial impact can also be pernicious and
far-reaching, with studies from diverse country settings reporting high levels of stigma, discrimination,
isolation, and mental illness, in people with TB [11,39,45–49]. While the TB Patient Cost Surveys
described above were able to measure the economic impact to people with TB and their households,
they were unable to shed light on the psychosocial impact of TB. Nor did these studies offer insight
into suitable designs of integrated socioeconomic support interventions that could address both the
psychosocial and economic implications of TB disease in Nepal.
Since March 2018, a Wellcome Trust funded research project (209075/Z/17/Z), nested within the
IMPACT-TB project, has been implemented in four districts of Nepal (Makwanpur, Chitwan, Dhanusha
and Mahottari) to generate new local evidence to fill this knowledge gap. The mixed-methods research
consisted of complementary studies: a cohort study of 221 people with TB recruited to the IMPACT-TB
study (half of whom were found by ACF) with a cross-sectional comparator group of 120 TB-unaffected
controls, selected by convenience sampling from communities within the same study sites, to evaluate
the socioeconomic determinants and consequences of TB in Nepal; and a qualitative study gathering
opinions of key stakeholders on the barriers and facilitators to accessing and engaging with TB
diagnosis and care in Nepal. The same stakeholders were subsequently invited to the final phase of
the research, the national workshop reported here, at which the preliminary findings of the cohort
and qualitative study were disseminated. The primary aim of the workshop was to create a shortlist
of feasible, locally appropriate socioeconomic interventions for TB-affected households in Nepal,
which have the potential for further evaluation for scale-up through randomized controlled trials.
Preliminary analyses of the cohort study data, presented during the workshop, showed that the
social determinants and consequences of TB in Nepal were consistent with those found in diverse
settings. After adjusting for age and sex, people with TB were more likely than TB-unaffected controls
to have lower education levels, be unemployed, have greater food insecurity, use non-renewable
smoke-producing fuels to cook, and perceive that they did not have enough money to meet their
needs. Despite people with TB reporting high rates of trust and belonging in their local communities,
one third of people with TB reported depression and/or anxiety, which was significantly higher than
reported rates in TB-unaffected controls. This depression and anxiety may be compounded by stigma,
which was reported by people with TB as prevalent, both in terms of self-stigmatization and enacted
stigma experienced in the community.
The qualitative study consisted of seven focus group discussions (FGDs) with 54 purposively
selected key stakeholder participants. The stakeholders were pragmatically categorized into three
groups: people affected by TB (consisting of 14 people affected by drug-sensitive TB, and seven
affected by drug-resistant TB), community stakeholders (consisting of community leaders and elders,
and representatives of grass-roots civil society organizations), and TB healthcare professionals
(consisting of National TB Program (NTP) managers, physicians, community health workers,
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and volunteers who were associated with the NTP). Initial analyses of FGD discussions found
that they focused on three major themes related to barriers and facilitators to TB diagnosis and care:
socioeconomic condition, access to healthcare, and provision of healthcare. Within these themes,
the identified barriers for people with TB in Nepal included economic hardship associated with TB
illness, diagnostic delays (especially relating to patient pathways consisting of both public and private
healthcare seeking), anxiety, and stigmatizing behavior from healthcare workers (Figure 1).
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2.3. Section 1 of the Workshop
Section 1 of the worksh p opened with presentations from the BNMT team highlighting the
literatu e revi w and finding t studies su marised above. This led on to a rese tation by the
Chief of the Quality, Standar a d Regulation Division of the Ministry of Health and Population,
highlighted the advances that Nepal has made towards improving access to healthcare and reducing the
financial burden on patients and their households, through the implementation of social protection [43].
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Nepal’s Social Security Act of 2017 legislated for a free package of basic healthcare and was expanded
to cover more illnesses in 2018 through National Health Insurance regulation [50]. Social protection,
including cash transfers, has been provided for some years to certain groups in Nepal (including old
age allowances, child grants, and a recent, small-scale pilot scheme of grants for the ultra-poor) [51,52],
and following humanitarian crises such as the 2015 earthquake [53].
During workshop discussions following the presentation, it was noted that, in order to achieve
expansion of social protection coverage, increased funding and resources would need to be ring-fenced,
across health, social care, and financial departments and sectors, political will would need to be
mobilised, and that complementary community knowledge and awareness strengthening activities
regarding TB would be essential. As one participant who leads a hostel for people with multi-drug
resistant TB (MDR-TB) in Nepal suggested, “We need to open our eyes to social protection for
TB-affected people, which must be effective, cost-effective, and evidence-based”.
Workshop participants then reviewed and discussed the current economic support provided to
people with TB in Nepal. It was noted that NTP-provided economic support predominantly focuses on
ensuring access to hostels and covering nutritional and travel costs for people with drug resistant TB
(DR-TB). This economic support amounts to Nepalese Rs. 3000 (approximately USD 26) per month for
ambulatory patient and Rs. 1000 (~USD 9) per month for hostel-based patients throughout treatment.
Workshop participants reported that the original impetus for this scheme was a perception that people
with DR-TB in Nepal face the greatest psychosocial and economic challenges in accessing and engaging
with care. Economic support is not routinely provided to people with drug sensitive TB (DS-TB) but,
in late 2018, the government of Nepal committed to initiate a social protection programme for people
with TB and HIV in Nepal. It was noted during workshop discussions that the current economic
support has received limited impact evaluation and there was agreement that expansion of coverage to
include other vulnerable people with TB should be considered [34].
2.4. Section 2 of the Workshop
(i) Identifying the existing psychosocial and economic support available for TB-affected households
in Nepal
Participants were purposively split into six, small multi-disciplinary groups to discuss: the existing
NTP-led psychosocial and economic support interventions for TB-affected households in Nepal;
the advantages and disadvantages of each (including intervention design, logistics of delivery and
implementation, funding and sustainability, acceptability to TB-affected households and impact if
known); what refinements or improvements could be made to the existing intervention; and what
related, new, potential interventions could be implemented and by whom such interventions would
be delivered and funded. Each group was randomly assigned a specific discussion area: Groups 1
and 2 discussed the psychosocial element of interventions; and Groups 3 and 4, the economic element.
Groups 5 and 6 discussed issues surrounding to whom such support is or should be targeted (e.g.,
all TB-affected households, only those with drug-resistant TB, only those in extreme poverty or with
other features of vulnerability). The workshop agenda and group work materials can be found in the
Supplementary Files.
Groups 1 to 4 identified that TB medication adherence counselling existed in Nepal, as did cash
transfers for food and nutritional support, solely for patients with DR-TB (Table 1). The groups
suggested that psychosocial counselling should also be offered that goes beyond existing medication
adherence counselling and which could be integrated with counselling packages for other illnesses
(e.g., diabetes). Additionally, it was agreed that mutual peer support groups would be beneficial
(especially if led by TB survivors). Finally, the groups recommended that current cash transfer amounts
were insufficient and should be increased, and coverage extended to other vulnerable TB-affected
people (Table 1).
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Table 1. Current and potential psychosocial and economic interventions.
Intervention
Element
Existing Interventions Refinements of
Existing Interventions
Suitable Potential
Interventions
Mode of Delivery
Psychosocial Routine NTP-led
counseling for TB-affected
people, which focuses
solely on TB treatment
adherence
There is no routine
counselling available to
address the psychosocial
impact of TB (e.g., stigma)
Existing counselling
about adherence to TB
medications could be
supplemented by
complementary
psychosocial
counselling
Educational and social
awareness campaigns
Provision of
complementary
counseling focused on
stigma, low mood
and depression,
and isolation and
marginalization
Integrated
psychosocial
counseling for people
with TB and
comorbidities (e.g.,
diabetes, depression)
Psychosocial counseling to
patients/households by
trained health workers in
healthcare facilities or in
people’s homes
Peer counseling and
mutual support (“TB
survivors group”)
Research into psychosocial
status of TB-affected
people throughout
treatment, especially
vulnerable groups
Economic Rs 3000/month as
nutritional/transport
allowance for ambulatory
DR cases
Rs 1000/month for
hostel-based DR cases
Community-based DOT:
Rs 1500 for volunteers,
Rs 500 for health worker
For people with
DS-TB
Rs 1500/month
nutritional allowance
for every DS case
Rs 500/month transport
allowance (conditional)
for DOT and follow up
Rs 1000 for side effect
management
(conditional)
For people with
DR-TB
Rs 3000/month for
transportation
Rs 2000/month for
nutrition
Rs 5000 for side effect
management
(conditional)
Income generation
activities or
back-to-work schemes
Cash transfer schemes
Incentivized TB
screening program
(e.g., economic,
nutritional, or other
incentive for attending
TB screening facilities,
being screened for TB
if appropriate, and/or
having a positive TB
smear or culture)
Nutritional package
program for
TB-affected person and
their household
Conditional cash transfer
through bank accounts or
mobile phones
Household visits to reduce
travel costs and support
TB treatment and
prevention activities
Partnering with local
organizations to provide
support and DOT
Community sensitization
and mobilization
Microcredit and vocational
training
(ii) Targeting of the intervention and potential funding sources
Groups 5 and 6 noted that a sizeable proportion of people with both DS- and, to a greater extent,
DR-TB, have significant side effects from medications (including for example nausea and vomiting,
diarrhea, or leg pains from peripheral neuropathy) but had to pay additional fees for medications
to control these side-effects. Therefore, people with side effects were identified as a potential target
recipient group. Groups 5 and 6 were unable to resolve a debate concerning whether support packages
should be implemented using a blanket “one-size-fits-all” approach or a stratified, needs-based
approach based on vulnerability as defined by eligibility for existing social protection schemes (Table 2).
Concerns were raised about stratified approaches being logistically difficult to deliver and creating risk
of misclassification of households (e.g., households classified as not vulnerable and therefore ineligible
to receive support which are vulnerable and would benefit from receiving support).
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Table 2. Definitions of vulnerable groups and benefits and drawbacks of targeted support.
Vulnerable Groups Targeting Support Benefits Drawbacks
• Economic status
(defined by eligibility
for existing social
health
insurance programs)
• Limited geographical
access to healthcare
• Co-morbidities (e.g.,
HIV, diabetes)
• Other specific groups
including: children,
elderly population,
pregnant women,
separated men and
women, ethnic
minorities, people
with disabilities,
homeless, daily
waged workers
or unemployed
Two main options for
provision of socioeconomic
support were discussed:
• a blanket “one size fits
all” approach given
that the majority of
TB-affected households
are economically and
socially deprived
• support stratified
by estimated
socioeconomic
vulnerability defined
by meeting eligibility
criteria for existing
social health insurance
and/or meeting other
definition of belonging
to a vulnerable group
• Needs-based
socioeconomic support
• Address both
socioeconomic
determinants and
consequences
of tuberculosis
• Enhance early
diagnosis and prompt
treatment and
potentially
interrupt transmission
• Improve TB case
notification, treatment
adherence and outcome
• A rights-based
approach would ensure
fundamental human
rights for health
were met
• Reduces stigma and
discrimination as well
as awareness
• Mitigation of
catastrophic costs by
defraying both direct
and indirect TB-related
costs (e.g., lost income)
• Chances of bias and
mis-categorization of
TB-affected
households as
vulnerable or
not with
stratified support
• Concerns were raised
concerning the
potential for creation
of dependency on
support beyond TB
illness among the
person with TB and
their household
• Huge economic
burden to the country
and health system of
implementing and
scaling up
socioeconomic support
• Financial feasibility
and sustainability
would depend on
start-up and
maintenance costs of
support scheme and
funding stream (e.g.
burden on National
TB Program or costs
shared across
governmental
departments
including, for
example, those
related to health,
social inclusion, and
job security)
• Concerns were raised
concerning
accountability and
transparency of
the program
All groups acknowledged that any increased funding would have to be co-funded between the
NTP and NGOs, external donors (including, but not limited to, the Global Fund, USAID, Damien
Foundation, TB-REACH, SAARC), or ideally across other governmental departments and ministries.
Concerns were raised about the initial level of funding required and whether this would be sustainable
in the long-term. It was also noted that, in the case of Nepal, the funding would have to be mobilized
and coordinated across the national, provincial, and local levels.
(iii) Designing and voting on the most suitable interventions for evaluation in a trial
Based on the mixed-methods research findings, workshop discussions, and feedback from the
group work, two potential outline options were generated for the psychosocial and economic elements
of an intervention that could be evaluated as part of a trial in Nepal (Table 3). The psychosocial
element included a community-based DOT provider or community health volunteer (CHV) being
trained to assess stigma level during a household visit and then inviting the household to participate
in either a peer-led mutual support group at district level [36] or a psychosocial counselling session
about TB-related stigma and how to overcome it. Both the support group and counselling session
Trop. Med. Infect. Dis. 2020, 5, 98 9 of 13
would include education about citizens’ and patients’ rights, smoking cessation, indoor air pollution
avoidance, and TB treatment and prevention. It was noted during the workshop that community-based
DOT would have the complementary impact of partially mitigating costs and time associated with
travel to DOTS clinics. Overall, 79% (30/38) opted for the household-level educational and psychosocial
counselling session. The economic elements included a monthly basic cash transfer for all patients and
people with DR-TB in hostel (at amounts above existing transfers, see Table 3) plus either conditional
cash transfers for medication side effects arising during treatment or additional cash transfers for those
TB-affected people or households deemed high-risk or vulnerable by the program. Definition of what
constitutes high-risk was debated and not agreed upon, but would be likely to include elderly patients,
single female patients, those living in extreme poverty, the homeless or people in unstable housing,
and people unemployed. A total of 30/34 (88%) voted in favor of additional cash transfers for high-risk
TB-affected people or households (Table 3).
Table 3. Design of and votes for psychosocial and economic elements of potential integrated
socioeconomic support package for people with TB.
Psychosocial Package Votes Economic Package Votes
A. CB-DOT provider / CHV assesses
stigma level at household visit (or in
hostel) and invite whole household to
local mutual peer support TB group
21% (8/38) A. Economic intervention:
• Monthly basic cash transfer for all patients (DR-TB
NRs 6000; DS-TB NRs 1000)*
• Pocket money for people with DR-TB in hostel
NRs 1500
• Conditional cash transfer for medication side effects
to health centre (DR-TB 5000 NRs; DS-TB 1000 NRs.)
12% (4/34)
B. CB-DOT provider / CHV assesses
stigma level at household visit and do
stigma counselling session with
household during visit
79% (30/38) B. Economic intervention:
• Monthly basic cash transfer for all patients (DR-TB
NRs 6000; DS-TB NRs 1000)*
• Pocket money for people with DR-TB in hostel
NRs 1500
• Additional cash transfer for socially high-risk
persons (to be defined) with TB (3000 NRs.)
88% (30/34)
Legend: The anonymized vote took place at the end of the workshop. Thirty-eight participants were present to
cast votes. The option of not casting a vote was given and four votes were not cast for the economic element of
the intervention. The sections of the cells that are underlined show the differences between psychosocial packages A and B,
and economic packages A and B. The sections of text not underlined in these cells show the elements which are the same in both
psychosocial packages A and B, and economic packages A and B.
3. Recommendations and Conclusions
This national workshop was the first of its kind in Nepal to review the evidence concerning the
socioeconomic determinants and consequences of TB and to design a socioeconomic intervention
package for TB-affected households. The workshop brought together key stakeholders from different
sectors, including people with TB and DR-TB, and reviewed the latest local evidence on the
socioeconomic impact, barriers, and facilitators of accessing and engaging with TB diagnosis and
care in Nepal. The presentations and discussions during the workshop elicited that TB-affected
people in Nepal face severe financial, social, mental, geographical, and health system level challenges.
More broadly, it was repeatedly noted that the current low coverage of social protection in Nepal is likely
to increase households’ vulnerability to poor health and worsening impoverishment, thus reinforcing
the vicious cycle of TB and poverty. To address this, the participants agreed that comprehensive social
and economic support was required for TB-affected households, which builds on the limited existing
platforms. The wider recommendations arising from the workshop are summarized in Box 1.
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Box 1. Five key recommendations suggested during the workshop.
The workshop recommended comprehensive support strategies, including psychosocial support and
economic support, for people with TB.
1. Psychosocial support: Psychosocial counseling should be incorporated into existing NTP activities to
improve mental health of all people with TB. Counseling by health workers or community volunteers at
the point of TB care, OPD visits in public and private health facilities, and/or during community-based
DOT and household visits, could support people with TB to cope with the psychological impact of the
disease, and potentially improve TB treatment adherence and outcomes. A more detailed evaluation and
assessment of mental health of people with TB is required.
2. Economic support: To reduce the financial burden of TB, the current cash transfer amount for people with
DR-TB should be increased and this economic support extended to people with DS-TB, especially the most
vulnerable (e.g., the most impoverished, unemployed). It was also recommended that additional budget
be provided to healthcare centers to subsidize provision of medication to treat people experiencing adverse
effects of TB medication or requiring related ancillary services. A national TB Patient Costs Survey would
provide more accurate estimates of out-of-pocket and lost income costs incurred during TB treatment,
which would support related policy translation.
3. Social protection: Coverage of social protection packages should be expanded to other vulnerable
populations that are defined by national social health insurance program to reduce the likelihood of
developing TB disease.
4. Nutritional support: There is a need for nutritional support not only for people with MDR-TB but also
for people with DS-TB. This recommendation was seen to align with the evidence presented during the
workshop that people with TB, regardless of drug-resistant status, experienced high levels of food insecurity.
5. Education and public-private mix (PPM): A PPM approach is vital to avoid the unnecessary expenditure
incurred at private health care visits for diagnostic and treatment services that are free in the public
healthcare system. Educational campaigns to inform communities about TB signs, symptoms, and free
NTP TB diagnostic and treatment services would complement this approach. A PPM strategy has recently
been approved by the Ministry of Health and Population in June 2019 and will be crucial to make TB
diagnosis and treatment affordable.
The overarching aim of the workshop, to develop a shortlist of socioeconomic interventions for
TB-affected households to be evaluated in a randomized controlled trial, was achieved. The preferred,
chosen intervention integrated: (i) psychosocial counselling by a community-based DOT provider
or volunteer during a household visit to reduce stigma and increase TB-related knowledge;
and an enhancement of the amount of the existing nutritional and transport economic support
with expansion of the support coverage to more vulnerable TB-affected people. The evaluation of
socioeconomic vulnerability of TB-affected households and the design of the intervention are being
refined in conjunction with the NTP and multi-sectoral partners for future implementation and robust
evaluation in a large, randomized controlled trial.
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